Keywords: Novartis, Teva, Russia, RT-Biotechprom, Manufacturing facilities, Investment

Novartis and Teva announce expansion plans in Russia

Article | 05 July 2012

Print This

Swiss drug major Novartis (NOVN: VX) has signed an agreement with RT-Biotechprom, one of Russia’s largest pharmaceutical and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in